Research and Markets: OTC Pharmaceuticals: Global Group of Eight (G8) Industry Guide

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/lsgsqc/otc) has announced the addition of the "OTC Pharmaceuticals: Global Group of Eight (G8) Industry Guide" report to their offering.

The G8 OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 OTC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 OTC pharmaceuticals market
  • Leading company profiles reveal details of key OTC pharmaceuticals players' G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 OTC pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Highlights

  • The G8 countries contributed $75,419.5 million in 2013 to the global OTC pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.2% between 2009 and 2013. The G8 countries are expected to reach a value of $82,703.5 million in 2018, with a CAGR of 1.9% over the 2013-18 period.
  • Among the G8 nations, the US is the leading country in the OTC pharmaceuticals industry, with market revenues of $29,272.9 million in 2013. This was followed by Japan and Germany, with a value of $14,956.6 and $7,927.1 million, respectively.
  • The US is expected to lead the OTC pharmaceuticals industry in the G8 nations with a value of $31,913.3 million in 2016, followed by Japan and Russia with expected values of $15,991.8 and $8,983.8 million, respectively.

For more information visit http://www.researchandmarkets.com/research/lsgsqc/otc

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals